Pendahuluan KN DR Gani
Pendahuluan KN DR Gani
SMT
I K
P RAKT
a ru
MA
k P
R I S id i
O
2018
TE
R II/
H a ti
S i d ik
i k P a ru O t a k
Sid Hati
TER
S id ik
KL A
k u l a ng
id i T
-201
S d i k
O t ak S i
S id i k d ik
l an g S i
r a m
II A-B
Tu o g
I
i d i k m R e n id
9
S g r a Ti ro
R e no ta ke
id i k U p
S
Tiro i d ah
a k e i m b
U pt L k t if
h R a di o a
L imba ktif
adioa
R
Ilmu Kedokteran
Nuklir
WHO/IAEA 1988
1. Cipto Mangunkusumo GH(SPECT/CT)
Adam Malik GH
2. Pertamina GH(SPECT/CT)
(SPECT/CT)
3. Gatot Subroto GH(SPECT)
4. Kanker Dharmais GH(SPECT/CT, PET/CT)
5. Jantung Harapan Kita GH(SPECT/CT)
6. Gading Pluit GH(PET/CT)
7. MRC Cancer Center (SPECT/CT, PET/CT)
M. Djamil
M. Djamil GH
GH
Wahidin GH
Kariadi GH
(SPECT-CT)
Sardjito GH
Hasan Sadikin GH
Seotomo GH
HasanSPECT
Sadikin GH
SPECT (2)
SPECT/CT
SPECT/CT
PET/CT(2) Nuclear medicine centers in
Role of Imaging Modalities
Anatomy Physiology Metabolism Molecular
X-Ray/CT NM
US
ANATOMI
MRI
LABORATORIU
Nuclear M
Optical
Role of Nuclear Medicine Techniques in
Imaging
millimolar
X-ray Sensitivity
CT Structure And
MRI Specificity
Physiology
Ultrasound
SPECT
PET Metabolism
MRS
picomolar
PET Drug Distribution
(MRS)
CT – computed tomography
PET Molecular Pathways
MRI – magnetic resonance imaging
MRS – magnetic resonance spectroscopy
Molecular Targets/
PET – positron emission tomography
PET Receptors/
SPECT – single photon emission tomography
Binding sites
PET
SPECT
Price P. Trends in Mol. Med.
2001, 7(10), 442-446.
kto
t e
De
r
Ra
a
dio
far
ma
k
Radiofarmaka untuk Diagnosis
Otak : 99m
Tc-ECD; 99m
Tc-HMPAO; 99m
TcO4;
Tulang : 99m
Tc-MDP; 99m
Tc-HEDSPA
Ginjal : 99m
Tc-DTPA 99m
Tc-DMSA
DSG
Clinical Images
Indications
Determine
thyrotoxicosis Graves’ Thyrotoxicos Toxic
causal is Factitia / Autonomou
Disease
Struma s Nodule
Ovarii
Marine- Subacute Plummer’s
Lenhart Thyroiditis / Disease
Syndro Iod Basedow
me Syndrome
Assesment of
struma and/or Simple Cold
nodule Nodule
Goiter Thyrogloss
Struma
aDuct Cyst
Asymme Hot
tric Nodule
Congenital Struma
thyroid
disorders
Dyshormogenesi
s
Agenesi Sublingua Hemiagenesi
Assesment of s l s
thyroid cancer Post-total Thyroidektomi Post-total
w/o Thyroid Tissue Thyroidektomi with
Remnant Thyroid Tissue
Remnant
SIDIK JANTUNG
Indikasi :
Sreening dan
stratifikasi /PJK
EF
Viabilitas miokard
Follow up steam MPI dan Viabilitas
cell
Indikasi GFR:
Menilai fungsi per-
ginjal
follow up tranplantasi
Indikasi Reno:
Restaging fungsi ginjal
Uji hipertensi Vaskuler
Evaluasi Obstruksi GFR dan RENOGRAFI
Evaluasi trauma ginjal
SIDIK HEPATOBILIARY
Hepatobiliari
Sidik tulang/Bone Scan
Indikasi :
Membedakan
keganasan dgn
infeksi
Identifikasi
cancer
Follow up
pasca
terapi
Staging
Restaging
Sidik Ongkologi Indikasi :
Sreening cancer
Identifikasi cancer
Follow /Evaluasi
Staging / Restaging
Sidik Pendarah bagian bawah abdomen
Limfoscintigrafi
LABORATORIUM
Pelayanan Laboratorium KN
•TSH sensitive
•T3
•free T4
•Tiroglobulin (Tg)
•Antibodi Antitiroglobulin (ATA)
LABORATORIUM (RIA/IRMA):
LABORATORIUM (RIA/IRMA):
TERAPI
Pelayanan Terapi KN
kto
t e
De
r
Ra
a
dio
far
ma
k
1. Prinsip 18F-FDG-PET akan masuk
dalam proses glikolisis.
2. 18F-FDG-PET dibuat di Cylotron
3. Radiofarmaka lain yang dihasilkan
Cylotron : 11C , 15O dan 13N
4. Fluorodeoxyglucose (FDG)
F18-FDG PET-CT Neuroblastoma
Indikasi :
Peny
Sebrovasculer
Demenctia
alzheimer
Cancer
Epilepsi
Mati Otak
Mohon doa dan partisipasinya
PET-CT ……………………2017
KONTRA
INDIKASI